Among them, AKT1 and IL‐6 are the core targets and key downstream factors of the PI3K/AKT inflammatory pathway, respectively, which suggests that the mechanism of action of Solid Formula to improve renal fibrosis may be related to the PI3K/AKT pathway. The gene discussed is AKT1; the disease is renal fibrosis.